Clinical Trial Update: Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and pharmacokinetics of the UB-421 antibody in asymptomatic HIV-1 infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UB-421 antibody (UB-421)

Snippet

Sponsor: United Biomedical | Conditions: HIV-1 Infection in Adults (Asymptomatic) | Phase 1 | Status: COMPLETED